HU9600758A2 - Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption - Google Patents

Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption

Info

Publication number
HU9600758A2
HU9600758A2 HU9600758A HU9600758A HU9600758A2 HU 9600758 A2 HU9600758 A2 HU 9600758A2 HU 9600758 A HU9600758 A HU 9600758A HU 9600758 A HU9600758 A HU 9600758A HU 9600758 A2 HU9600758 A2 HU 9600758A2
Authority
HU
Hungary
Prior art keywords
diminished
enhanced biological
gastrointestinal irritation
diclofenac composition
biological resorption
Prior art date
Application number
HU9600758A
Other versions
HU9600758D0 (en
Inventor
Peterne Csabai
Eva Fenyvesi
Andrea Gerloczy
Jozsef Szejtli
Wilfried Fischer
Anna Sendl-Lang
Original Assignee
Cyclolab Ciklodextrin Kutato F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclolab Ciklodextrin Kutato F filed Critical Cyclolab Ciklodextrin Kutato F
Priority to HU9600758A priority Critical patent/HU9600758A2/en
Publication of HU9600758D0 publication Critical patent/HU9600758D0/en
Priority claimed from HU9903230A external-priority patent/HU9903230A3/en
Publication of HU9600758A2 publication Critical patent/HU9600758A2/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/922Side effect reduction by incorporation of a second designated ingredient
HU9600758A 1996-03-27 1996-03-27 Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption HU9600758A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9600758A HU9600758A2 (en) 1996-03-27 1996-03-27 Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
HU9600758A HU9600758A2 (en) 1996-03-27 1996-03-27 Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
BR9708280A BR9708280A (en) 1996-03-27 1997-03-27 diclofenac inclusion compounds / gamma-CD
DE69710574A DE69710574D1 (en) 1996-03-27 1997-03-27 Diclofenac / gamma-cyclodextrin clathrate component
JP9534053A JP2000507258A (en) 1996-03-27 1997-03-27 Diclofenac / gamma - cyclodextrin inclusion compound
AT97919309T AT213410T (en) 1996-03-27 1997-03-27 Diclofenac / gamma-cyclodextrin clathrate component
PCT/EP1997/001595 WO1997035568A2 (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds
ZA9702707A ZA9702707B (en) 1996-03-27 1997-03-27 Diclofenac/Gamma-CD inclusion compounds.
AU23829/97A AU713902B2 (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds
CN97194134A CN1217658A (en) 1996-03-27 1997-03-27 Dicloroanilicnophenylacetic acid/gamma-cyclodextrin inclusion compounds
HU9903230A HU9903230A3 (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds and pharmaceutical compositions containing the same
PL97329036A PL329036A1 (en) 1996-03-27 1997-03-27 Inclusive compounds of diclophenac and cyclodextrin
CA002250009A CA2250009A1 (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds
EP97919309A EP0893994B1 (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds
US09/155,298 US6071964A (en) 1996-03-27 1997-03-27 Diclofenac/gamma-cyclodextrin inclusion compounds

Publications (2)

Publication Number Publication Date
HU9600758D0 HU9600758D0 (en) 1996-05-28
HU9600758A2 true HU9600758A2 (en) 1998-03-02

Family

ID=10988187

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600758A HU9600758A2 (en) 1996-03-27 1996-03-27 Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption

Country Status (13)

Country Link
US (1) US6071964A (en)
EP (1) EP0893994B1 (en)
JP (1) JP2000507258A (en)
CN (1) CN1217658A (en)
AT (1) AT213410T (en)
AU (1) AU713902B2 (en)
BR (1) BR9708280A (en)
CA (1) CA2250009A1 (en)
DE (1) DE69710574D1 (en)
HU (1) HU9600758A2 (en)
PL (1) PL329036A1 (en)
WO (1) WO1997035568A2 (en)
ZA (1) ZA9702707B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2379854B (en) * 2001-09-19 2006-04-19 Walcom Animal Science Dairy cow feed and the use thereof
EP1465646A1 (en) * 2001-12-13 2004-10-13 Council of Scientific and Industrial Research Bioavailability enhancing activity of zingiber officinale linn and its extracts/fractions thereof
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
CN1232539C (en) * 2002-05-10 2005-12-21 刘云清 Match of organic medicine and beta-cyclodextrin derivative and its preparing process
JP5823093B2 (en) * 2006-03-28 2015-11-25 ジャヴェリン ファーマシューティカルズ インコーポレイテッド Low doses of diclofenac and β- cyclodextrin formulation
JP2009531451A (en) * 2006-03-28 2009-09-03 ジャヴェリン ファーマシューティカルズ インコーポレイテッド Low doses of nonsteroidal anti-inflammatory drug and β- cyclodextrin formulation
JP2009196922A (en) * 2008-02-21 2009-09-03 Glovia:Kk Sustained-release ferulic acid preparation
WO2009108828A2 (en) * 2008-02-27 2009-09-03 Dr. Reddy's Laboratories Ltd. Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
EP2422818A3 (en) * 2010-08-27 2013-01-16 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Process to produce a diclofenac cyclodextrin conjugate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5984821A (en) * 1982-11-04 1984-05-16 Teikoku Chem Ind Corp Ltd Slowly solubilized composition
IT1227626B (en) * 1988-11-28 1991-04-23 Vectorpharma Int Drugs having supported speed 'of increased dissolution and a process for their preparation
IT1241417B (en) * 1990-03-06 1994-01-14 Vectorpharma Int Therapeutic compositions with controlled release of drugs supportatisu crosslinked polymers and coated with polymer films, and their preparation processodi
IT1243342B (en) * 1990-07-13 1994-06-10 Farcon Ag Liquid oral pharmaceutical compositions having activity 'antiinflammatory
IT1247529B (en) * 1991-04-24 1994-12-17 Poli Ind Chimica Spa Pharmaceutical compositions in the form of foam for intravaginal, skin and oral
DE69231457T2 (en) * 1991-06-21 2001-05-23 Takeda Chemical Industries Ltd Cyclodextrin composition comprising fumagillol derivatives
DE4207922A1 (en) * 1992-03-13 1993-09-23 Pharmatech Gmbh New water-soluble inclusion complexes contg randomly substd. methyl-beta-cyclodextrin - for admin. of substances which are only sparingly soluble in water
AT246515T (en) * 1993-06-08 2003-08-15 Novartis Pharma Gmbh A process for the preparation of oral dosage formulations containing diclofenac
IT1264696B1 (en) * 1993-07-09 1996-10-04 Applied Pharma Res Pharmaceutical compositions intended for oral administration capable of releasing active substances at speed 'controlled and differentiated
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA9409182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
CA2250009A1 (en) 1997-10-02
EP0893994B1 (en) 2002-02-20
PL329036A1 (en) 1999-03-01
AU713902B2 (en) 1999-12-16
EP0893994A2 (en) 1999-02-03
CN1217658A (en) 1999-05-26
ZA9702707B (en) 1997-10-22
BR9708280A (en) 1999-08-03
US6071964A (en) 2000-06-06
WO1997035568A3 (en) 1997-12-04
JP2000507258A (en) 2000-06-13
WO1997035568A2 (en) 1997-10-02
DE69710574D1 (en) 2002-03-28
HU9600758D0 (en) 1996-05-28
AT213410T (en) 2002-03-15
AU2382997A (en) 1997-10-17

Similar Documents

Publication Publication Date Title
GB2285582B (en) Medical clip
GB2298422B (en) Compounds and their use
GB2322499B (en) Endoscope
GB2317778B (en) Endoscope
GB2300195B (en) Medical adhesive composition
TW575423B (en) Pharmaceutical composition for the treatment of pain
IN186843B (en) Hair treatment compositions
SG77197A1 (en) Disposable diaper
TW382258U (en) Disposable diaper
SG81939A1 (en) Disposable diaper
GB9704749D0 (en) Tissue Implant
PL319503A1 (en) Peptide compounds and their therapeutic application as inhibitors
IL135026D0 (en) Improved gunsight and reticle therefor
IL118825D0 (en) 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use
ZA9605650B (en) Treatment of arterloscierosis and xanthoma
IL118304D0 (en) Micro-encapsulated lactobacilli for medical applications
HK1023571A1 (en) Thienotriazolodiazepine compounds and medicinal use thereof
SG71093A1 (en) Disposable diaper
EP0787006A4 (en) Compositions and methods for human gastrointestinal health
IL119864D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
EP1088071A4 (en) 94 human secreted proteins
EP1019100A4 (en) Controlled release of substances
IL122428D0 (en) Minizymes and minribozymes and uses thereof
EP1100869A4 (en) 98 human secreted proteins
IL125803D0 (en) Dosage form of ibuprofen